Peter Barschdorff is Vice President, Business Insights, responsible for Primary Market Research, Advanced Analytics, Commercial Reporting at Bayer (U.S. Pharma). He also serves as Chairman of Bayer’s U.S. Market Insights Council and is a member of the U.S. Pharma Leadership Team.

In prior roles at Bayer, Peter built a 35-FTE strong in-house consulting team, and, more recently, served as the company’s global Chief Complexity Reduction Officer. In earlier stages of his career, he was a management consultant, i.a., at Deloitte Consulting and at Capgemini Consulting, as well as a defense researcher at NATO’s Parliamentary Assembly in Brussels (Belgium).

Peter received his Ph.D. from the Free University in Berlin (Germany), and his MBA from Columbia Business School.

As Director of Marketing for Healthcare Services & Solutions (HSS), a wholly-owned entity of Merck, Glenn leads customer engagement to better understand the intersection between demand in infectious diseases and the application of health information technology. Glenn joined HSS in 2014, and current responsibilities include leading engagement initiatives for ILÚM Health Solutions, an HSS company that leverages data within existing health IT systems to support hospital goals for improved outcomes for ID patients.

In addition, Glenn previously held leadership positions in Merck’s Global Human Health Division. Beginning in 2008, he had global responsibility for Merck’s Antibiotic portfolio, focusing on antimicrobial stewardship and enhancing scientific collaboration and access in emerging markets. In this role, Glenn led worldwide marketing and management of the Study for Monitoring Antimicrobial Resistance Trends (SMART), currently one of the largest ongoing epidemiology studies of tracking resistance. This global perspective, particularly throughout Asia-Pacific, provided Glenn a unique skill set and perspective when he transitioned to the US Anti-Infective franchise. Here, he led the development and implementation of an integrated strategy for Merck’s antibiotic and antifungal portfolio.

Glenn holds an MBA from Villanova University and a BS in Health Sciences from James Madison University.

Personally as well as professionally, Glenn values the principles of teamwork and commitment that he learned as a Division I Scholar Athlete in baseball. He shares those values not only in his work, but also as a youth sports coach.

Larry is the US Commercial Lead for SHP621. SHP621 is being developed as a treatment for Eosinophilic Esophagitis

Larry has over 17 years of experience in pharmaceutical/vaccine sales and marketing and has developed a reputation for being an effective leader, strategist, and planner.  He possesses a deep understanding of the pediatric vaccines market, having worked across multiple brands including Gardasil, MMRII, as well as the launches of Proquad, RotaTeq and MenHibrix.  Larry has also gained experience in pharmaceutical marketing as Marketing Director for the blockbuster cardiovascular products Zetia and Vytorin.   In addition to his experience as a product marketer, Larry has held positions in Sales, Marketing Communications, and Market Research.  In his prior role at GSK, Larry was the Senior Director of the Pediatric Vaccine Commercial Strategy Team and was responsible for delivering gross revenue greater than $1B.

Mike Capaldi is AVP, Civic Action, Policy Coalitions and State Government Affairs for Sanofi US in his 18th year with the organization.

He is responsible for encouraging civic action and employee engagement throughout the organization. This includes leading the grassroots platform, employee PAC and other civic action programs. Mike also collaborates with appropriate trade associations and external policy coalition groups for important industry issues. Finally, he is a member of the state government affairs team monitoring the legislative landscape in the states of CT, ME, NH, RI and VT.

Mike’s experiences include work in Corporate Social Responsibility and Training & Development for 12 years where he was responsible for the T&D of nearly 10,000 field and headquarter-based employees. Mike served as President of the Society of Pharmaceutical and Biotech Trainers in 2010-11. In 2007, he earned a Masters of Education in Corporate Training & Knowledge Management from Jones International University.

Nolan is an experienced strategic marketing leader with a strong track record of driving growth in highly competitive markets.  He has a proven ability to convert market insight into business opportunity and is known as a passionate and results-oriented brand management professional.

Nolan is Senior Manager of Respiratory New Product Strategy at Teva Pharmaceuticals where he is responsible for defining, aligning and implementing new product strategy of assigned products currently in development.  Prior to his current role Nolan led Professional promotion for the ProAir HFA brand.

He holds a B.S. in Computer Science from Rutgers University and a M.B.A. from the University of North Carolina at Chapel Hill.

Dan Henry is the Director – Marketing at Otsuka where he is responsible for the go to market strategy and execution of the Digital Medicine business.  He brings 18+ years of experience across sales and marketing in the surgical, pharma and consumer healthcare sectors.  Throughout his career he has held a diverse set of roles focused on the US, global and regional roles focused on Latin America and Asia Pac.

Dan is passionate about the rapidly evolving healthcare industry and had the opportunity to lead transformational efforts during his time at GSK Consumer Healthcare.   This includes leading a global team that helped to align the organization on the opportunity that Social Media presented as well as how it could be executed in markets around the world.  Additionally, while living and working in Asia, he led an effort to transform the organization’s selling teams that engaged with independent pharmacies to better meet their needs and those of patients that they serve. 

Bob Holliday is the Senior Director of General Medicines Training at Sanofi Pharmaceuticals. He has over 25 years of training experience with 15 in the pharma/biotech  industry. In that time he as lead the launch training of over 25 product launches both in the US and globally. He currently leads a team of 34 dedicated to developing a comprehensive curriculum for the General Medicines business of over 3000 sales professionals and leaders. The team has already launched 3 new products this year and has 4 more in development.

Brad has 15 years of experience in the healthcare industry. He has served in various sales, marketing, training, and management roles to support pharmaceuticals, biologics, medical devices, and pharmacy services. Currently, Brad is the Senior Director of Field Force Effectiveness at Entera Health (Cary, NC). In this role, he oversees all functions of the Sales Training, Sales Analytics, and Sales Operations Departments. Additionally, Brad works alongside the SVP of Sales in a field capacity to monitor consistency, identify learning gaps, uncover barriers to success, and ensure implementation of all sales and marketing initiatives.

Deputy director for commercial analytics from Bayer. Conducted hands-on commercial ROI and Marketing Mix analysis for multiple brands. Established and executed a framework to effectively measure the relationship between digital/social media marketing efforts and direct (sales) and indirect (awareness) returns.

Dr. John is leading our Hospital Transition in Care and our Employer Solutions programs. He is a practicing pharmacist, healthcare consultant, entrepreneur and patient advocate.  Dr. John has considerable expertise in the areas of patient engagement, population health management, transition in care and mobile health technology solutions. He serves as a medical advisor for a variety of companies focused on health/wellness, patient engagement and medication adherence.

Dr. John is also the Executive Director of NOVA Scripts Central a non-profit pharmacy that provides medications to uninsured patients in the Northern Virginia area. He is the founder of Urban Medical Solutions, which is focused on raising awareness of health literacy with in the underserved patient population.   Dr. John has previously worked in academia serving as an Assistant Professor of Pharmacy Practice at Massachusetts College of Pharmacy & Health Sciences where he developed innovative ambulatory care practice sites within federally qualified community health centers.  He has worked to train healthcare professionals in the areas of health literacy and cultural competency in order to address health dispartities.

Dr. John holds a Doctor of Pharmacy degree from St. John’s University in Queens, New York and has completed a pharmacy residency with Massachusetts College of Pharmacy & Health Sciences.

Richard Johnson is a Cialdini Method Certified Trainer (CMCT), personally trained by Dr. Robert Cialdini and Dr. Gregory Neidert, Director of Training, INFLUENCE AT WORK.

Richard holds a Master’s Degree in Human Resource Development and Training from Webster University. Additionally he holds undergraduate degrees in Sales and Marketing from Trident College and Charleston Southern University. Richard received the prestigious Merit Award in Marketing. Richard completed his Master’s program Summa Cum Laude from Webster University. His thesis focused on pharmaceutical sales and marketing excellence.

These areas of expertise combined with his experience as Sales Representative, Regional Field Training Coordinator, Hospital Sales Representative, Territory Manager, District Manager, Regional Manager, National Field Sales Director and Senior Vice President of Sales and Sales Training provide Richard with a unique blend of people development and business development skills.

Richard has spent the last 20 years developing world class sales teams with a special emphasis on the pharmaceutical and medical industry. During this time, Richard and his teams have won the highest sales awards in the industry thirteen times.

Dr. Ben Locwin is Global Head of R&D Learning at Biogen. He is an author for a variety of books and magazines, and has been featured by the CDC, the Associated Press, and the Wall Street Journal, among other media outlets. He is an expert contact for the American Association of Pharmaceutical Scientists (AAPS) and is a committee member for the American Statistical Association (ASA). He has developed methods improving how companies practice their marketing approaches in industries worldwide.

Katie MacFarlane, Pharm.D, has been our primary commercial advisor since 2009, and became our Chief Commercial Officer in March 2014. Ms. MacFarlane also serves as a Managing Partner of SmartPharma LLC., a pharmaceutical consulting firm specializing in new product commercialization since 2007. Previously, she served as President and Chief Executive Officer at Xintria Pharmaceutical Corporation, a start-up company in the development of berberine for treatment of dyslipidemia and Type II diabetes from 2006 to 2007. Prior to that, Ms. MacFarlane served as Vice President of Women's Health and New Product Planning at Warner Chilcott, an international pharmaceutical company focused on women's healthcare, dermatology and urology from 2001 to 2006. From 1991 to 2000, she served in management positions of increasing responsibility in clinical research, marketing and sales management with Parke-Davis, a division of Warner-Lambert and also held the position of Regional Sales Director and was responsible for sales force planning and implementation, including the integration with Pfizer, Inc., following the merger in 2000.  She received her B.S. degree in Pharmacy and Doctor of Pharmacy from Purdue University and completed a Postdoctoral Fellowship in Industrial Pharmacy Practice with Rutgers University and Hoffmann-LaRoche.  Ms. MacFarlane is also a member of the board of directors for RespireRx Pharmaceuticals, Inc.

Jennifer Muszik is the Director of Commercial Excellence at Roche. Prior to her current role, she was Director of Marketing Effectiveness on the US Commercial Effectiveness team for Pfizer Inc.  She led specific projects and programs to advance productivity across Primary Care by improving effectiveness of customer interactions, evolving customer models and developing and scaling of evolved messaging.  Jennifer joined Pfizer in 1998 and has held several other positions in Pfizer including Director of Field Force Effectiveness, Account Management, District Business Manager, Operations, and Field Sales.  Jennifer has been recognized for her performance with three Summit Awards – the highest performance award, in 2000, 2011 and 2012.  She has also been nominated for two Innovation Awards for projects, receiving the award in 2010. 

Jennifer dedicates a great deal of time to women’s development and is honored to serve as the 2015 Healthcare Businesswomen’s Association Indiana Chapter President.  She previously held both President-Elect and Director of Corporate Relations & Business Development positions for the HBA-IN Chapter.  Jennifer also serves on two boards at Butler University – the Alumni Association Board of Directors and the College of Business Strategic Marketing Board.  Jennifer is an Executive Advisor for the Butler University (Epsilon Beta) Chapter of Alpha Phi and served as a facilitator in the 2014 Alpha Phi Emerging Leaders Institute – a values-based leadership program for collegians across the US and Canada.

Due to Jennifer’s depth of experiences, she has been asked to speak for several local and national organizations, as well as inside her current organization.  Professionally, Jennifer has spoken on Evolving the Commercial Sales Model and on The Impact of the Evolving Healthcare Market on Pharma Marketing and Sales.  She also speaks on her personal passions: The Importance of Individual Development Plans and The Importance of Mentors, Sponsors and Connectors.

Jennifer holds a Bachelor of Business Administration from Butler University in Indianapolis, Indiana.  Jennifer currently resides in Zionsville, Indiana with her husband, Paul, and their three children, Paulie, Noah and Sarah.

Sreenath Nampally (Sree) is a technology and business leader with significant master data management, data integration, data aggregation, reporting, analytics, program management and customer engagement experience in the Pharmaceutical and Life Sciences industries.  In his current role, he leads the Oncology sales data aggregation (specialty pharmacy and distributor data), data integration and data services.  He leads a team of data and technical analysts to provide data services to several key stakeholders including Sales, Marketing, Marketing Sciences, Brand Insights, Hub Services, Channel Management and Market Access.

Sree holds an MBA from Carey Business School of Johns Hopkins University and an MS in Computer Science from George Mason University.

Brian Peters is Vice President, Marketing, for Medac Pharma, Inc, where he recently led the launch efforts for Medac Pharma’s first product. He brings 25 years of both client and agency side strategic pharmaceutical marketing experience to the PharmForce meeting. Working in a small company environment, he wears many hats and brings a unique perspective on the challenges of pharma marketing with limited resources.

Quang Pham is Chairman and CEO of Espero Pharmaceuticals, an emerging growth cardiovascular company with two in market products and a PDUFA action date of June 10, 2016 for the first new acute angina treatment in the US in two decades.

Mark has over 20 years of experience partnering with Executives to make technology investments that drive business results.  Mark is currently Business Technology Lead for Cardiovascular Metabolic at Pfizer. He has been leading the Global Innovative Pharma Digital Program for the last 2 years to target investments in emerging areas of digital healthcare. He also co-leads Quitter’s Circle, an innovative digital program to get smokers to engage in HCP assisted quits. During his 18 years at Pfizer, Mark has held several leadership roles in Business Technology, helping executives exploit marketplace opportunities using technology and process including: Commercial Operations, Specialty & Oncology, Drug Portfolio Management, Primary Care U.S. and Pfizer Health Solutions.
 
Prior to his career at Pfizer, Mark was an Engagement Leader with Arthur Andersen Business Consulting for 8 years. During this time he led many large-scale business transformation programs for such companies as NYNEX, GTE, Columbia Gas and Weyerhaeuser Mortgage. Mark was a key player in developing the Arthur Andersen's Business Consulting practice in both the Los Angeles and New York.

Currently with Novartis Pharmaceuticals, Najur has over 15 years in the Pharma industry, working in a variety of roles for companies such as Wyeth Pharmaceuticals, Pfizer, J&J & IMS Health.

Najur originally started his career as a Facilities Management Project Engineer working for the Minneapolis Public Schools and then later in the airline industry, initially in Operations Research/Revenue Planning for Northwest Airlines and finally in Frequent Flyer program marketing for US Airways

He has degrees in Economics/Statistics, International Studies & Mechanical Engineering.

Kevin is currently leading the digital strategy, innovation and execution for the ORENCIA and NULOJIX brands. He has spent 17 years in the Pharmaceutical Industry, with experience spanning Sales, Sales Leadership, Brand Management and Digital Marketing.

After starting off his career in radio, Adam D. Shandler has spent the last 15 years helping companies in the healthcare sector achieve their recruiting and training goals. While at Medco Health, Adam led a project management team charged with filling 100 customer-facing positions when the company spun off from Merck. He also developed the company’s campus recruiting programs, including Medco’s MBA Development Program. At Stryker, Adam developed a “hiring culture” at the company’s Spine division and launched the division’s first Training & Development program. Parlaying his wins in Talent Management, Adam then led Stryker’s East Region Talent Acquisition team, improving this COE’s engagement scores by a full two points and improving customer satisfaction scores over prior years.

Currently, Adam leads Talent Acquisition and Talent Development at Dr. Reddy’s Laboratories, North America. He is relentlessly focused on building a stronger digital employer brand for the company and is developing a leadership development program for high-potential managers.

Adam believes that better employer branding drives better talent acquisition, and retention happens through building community within departments.

Adam is happy to connect on LinkedIn. His twitter handle is @adshandler.

Strategic Leader with extensive Biotech and Pharmaceutical experience at AstraZeneca, MedImmune, Human Genome Sciences, Novo Nordisk and Cegedim delivering business enabling capabilities through innovative solutions that connect strategy, people, process and technology across multiple therapeutic areas. 

Edward is customer focused with a solid track record of successful business relationship management, leadership and transformation while working in collaboration to achieve enterprise goals. Proficient at leading multiple Commercial programs in a fast-paced cross-functional environment leveraging in-depth business, technical and communication competencies that quickly create rapport and credibility with diverse commercial business & technology leaders.

Sandra is currently the Content Strategy Leader at Merck, part of the Customer Engagement Capabilities Center of Expertise.  She leads a team that is deploying a new approach to content strategy, design, sourcing and delivery of relevant customer content via multiple channels with speed and efficiency and leading to superior customer engagement.
Prior to this role, Sandra was the Digital Marketing Strategy Leader for International Markets.  She led a team of experts that consulted with international markets at Merck as they develop and execute on their Digital Customer Engagement strategy and providing expertise in developing digital marketing strategies and roadmaps.
Sandra has also held various leadership roles within Merck in Global Commercial Support, specializing in Key Account Management and Marketing Communications, working with top markets and Regions.  Sandra joined Merck in 2007 and has worked in the U.S. Market and multiple Global roles.  She led merger integration strategy and execution for Global Customer Strategy and achieved her Master Black Belt and Change Agent Level 1 certifications.
Prior to Merck, Sandra worked for the Advanced Materials business of GE for 12 years.  She most recently worked in their GE Bayer Silicones Joint Venture as the Business Unit Leader for the Resins & Coatings Business located in Leverkusen, Germany.  Before living in Europe, Sandra held various field and HQ sales and marketing roles in the US and Latin America markets. 
Sandra has a B.S. in Chemical Engineering from the Massachusetts Institute of Technology (MIT) and an M.S. in Chemical Engineering from Worcester Polytechnic Institute (WPI).

Janardhan Vellore is the Head of Commercial Analytics, at Bayer Healthcare Pharmaceuticals, and leads the Management Science team tasked with advanced sales, marketing and payer analytics and commercial ROI analyses.  He was most recently Director for Analytics and Insights, leading a team of market researchers and analysts supporting specialty drugs across the various stages of the product lifecycle. In that role, he supported brand planning, led forecasting efforts, and drove productivity initiatives, to mention a few of his responsibilities.  Prior to Novartis, he held executive positions at Medco Health Solutions, and previously worked at ZS Associates, a management consulting firm.  Janardhan holds an MBA from The Wharton School, a Masters degree in Engineering from The University of Akron (OH), as well as a Bachelors degree from the Indian Institute of Technology, Madras.

Kevin Watson is a Director in the Global Marketing Practice at UCB, whose focus is on patient and stakeholder engagement.  Throughout his career, he has been a marketing strategist who has led transformative initiatives for Fortune 500 companies.  Kevin has over 18 years of experience as a hands-on technology practitioner, a management consultant, and a modern marketer. 

Larry is currently VP Value Based Care, at Pharmacist Partners.  Prior to joining Pharmacist Partners in 2015, he was Director, Healthcare Quality Alliances for the Strategic Customer Group for the Johnson & Johnson Institutional Franchise where Larry was responsible for providing franchise-specific strategic quality planning & perspective on current health system practices and future healthcare environment strategies. During his tenure in this position, Larry was appointed and served as a Member of the NQF National Priority Partnerships’ Care Coordination Workgroup.

Prior to joining Johnson & Johnson in 2005, Larry held a variety of leadership positions with Aventis Pharmaceuticals.

Larry received his BS in Pharmacy and Doctor of Pharmacy degrees from the University of Maryland and prior to his career in the pharmaceutical industry held several senior management pharmacy positions in the hospital, home care, and long term care segments. In addition, Larry has held faculty appointments at the University of Maryland School of Pharmacy and George Washington University School of Medicine where he taught geriatric pharmacotherapy. 

Keith has over 22 years of pharmaceutical industry experience and over 9 years of training experience.  He is currently Associate Director for Sales & Access Learning at Bristol Myers Squibb responsible CV training for both Retail and Institutional Representatives. Keith has also spent time at Pfizer, Wyeth, Johnson and Johnson and served as a captain in the US Army.

Lori serves B2B Marketing Professionals in all industries who must power up their processes, technology, and teams to achieve new customer acquisition and revenue and retention goals. She researches and advises on the core marketing operations of customer attraction,
nurturing, conversion, and life-cycle value management. The research manifests in a holistic lead-to-revenue management (L2RM) approach that leverages the right strategy, tools, tactics, and budget to execute customer-insight-based go-to-market strategies and plans that span both digital and traditional channels. Lori also covers the marketing automation software that marketers can deploy to scale operations, manage with metrics, and maximize return on investment.

Doron Aspitz is a visionary and seasoned executive, with over 20 years of technical and business management experience in growing technology companies in dynamic markets. Doron specializes in building and expanding early-stage companies with a customer-centric approach.
Doron was previously co-founder, chairman, and CEO of Blue Pumpkin Software, a leading workforce management solutions company. Blue Pumpkin received numerous industry accolades for transforming the way companies manage employees and improve their customers’ experience. Call Center Magazine awarded Doron with their “Pioneer of the Year” award as a tribute to his industry contributions. Doron drove Blue Pumpkin to achieve strong profitability and growth during difficult times and led the company to a very successful acquisition by Witness Systems (NASDAQ: WITS) in 2005. Prior to founding Blue Pumpkin, Doron held global business and senior technical management positions at Tandem Corporation and IBM. Doron holds a Masters in MIS and a B.Sc. in Economics and Statistics, both from the Tel Aviv University.

Born in New York, Michael grew up in Trumbull, Connecticut. He attended the University of Michigan for undergrad and went on to the University of Connecticut for medical school. After completing his residency in internal medicine at the University of Chicago Hospital in 2002, he left clinical medicine to pursue a career in medical education.
 
He is the President and Co-Founder of MDea, a creative medical education company in NYC, and The Doctor’s Channel, known as the “educational YouTube for doctors.”  Michael also serves as the Managing Director of BESTMSLs, a contract MSL organization, where he brings medical and technology expertise to field organizations.
 
Michael has a passion for technology and gadgets, the Mets and Jets, and his wife and two beautiful daughters, Ava and Jordan.

He was selected as one of the “Best Doctors in America” (as voted by his mother, Ilene Banks).

Jason Bhan, MD, is a Family Physician and serves as the Chief Medical Officer at Medivo. He is regarded as a national expert in the applications of technology to healthcare and medicine, a topic on which he speaks regularly at institutions and conferences, such as Health 2.0, mHealth, New York’s eHealth Collaborative, and Health Datapalooza. He also has done extensive strategy consulting with pharmaceutical companies.

From 2007-2010, Dr. Bhan worked with Clinovations and managed several large hospital system EHR implementations, outcomes measurements and data analysis. Dr. Bhan obtained his Doctor of Medicine at the University of Miami School of Medicine and he is board certified in Family Medicine.

Judson Chase is a Customer Success Director at Zephyr Health; the Insights-as- a-Service leader harnessing the power of global health data to help Life Sciences companies engage the right physicians, accounts and institutions. He is passionate about engaging customers and expanding their use cases by aligning product management and implementation teams around key performance goals.

Prior to joining Zephyr Health, Judson spent fifteen years working in customer management and business consultancy for technology companies serving Life Sciences industry. His strong background with technology firms, like Tibco and Oracle, position him uniquely to think proactively about the customers’ business needs to deliver meaningful value through the use of software solutions.

Judson holds a BS in Marketing from University of Georgia and clinical trial certifications from Boston College.

Paul Darling is a Principal with ZS Associates in the firm’s San Francisco office.  Paul assists life sciences companies in evaluating new markets, acquisitions, and licensing opportunities as well as developing the associated go-to-market strategies.  He has presented at several industry conferences on the topics of forecasting, asset valuation, and alliance structuring. 

Paul developed and leads ZS's Institute on U.S. Healthcare Evolution and Scenario Planning.  He is currently exploring opportunities for life sciences companies to take a broader role in patient health in the era of U.S. healthcare reform, including new business models, therapies, acquisitions, and partnerships, as well as reimagining the commercial model to support such portfolio changes.

Prior to joining ZS, Paul was a fellow at the Perelman School of Medicine at the University of Pennsylvania. He holds a B.S. in biochemistry from Boston College and a Ph.D. in Statistical Thermodynamics from Washington University.

Tamara Gaffney leads the team of analysts responsible for providing marketers with research and insights captured through aggregated and anonymous data from the Adobe Digital Marketing Cloud, one of the world’s largest marketing technology platforms with over 1.24 trillion transactions per quarter. In her role, she is frequently quoted ontelevision, radio and in thousands of press articles on a variety of data-oriented technology, and digital marketing topics where she uses big data to identify key trends and predict the future. Tamara was named one of the Top 20 Big Data Analysts in the US by Fortune Magazine and one of the Top 100 Data Influencers in the UK by DataIQ Magazine.

Tamara earned her MBA from Kellogg School of Management at Northwestern and her BS in business and minor in computer programming at the University of Southern California.

Jeff Gaus is the Chief Executive Officer of Prolifiq Software. He is responsible for articulating and overseeing the execution of the company’s growth strategy. Prior to his current role, he led the company’s business development, marketing and sales activities having initiated relationships with Prolifiq’s largest customers and partners.
Jeff is a 30+ year veteran of the telecommunications industry, has designed several communications protocols and has co-authored two United States patents: one for VoIP and the other for electronic message management – the core of Prolifiq’s platform.

Over the past 11 years, Amy has created healthcare and pharmaceutical advertising that informs, inspires and moves people to action. Her natural curiosity and deep understanding of strategy have enabled her to lead creative teams in more than a dozen successful brand launches and continue to drive success for all her clients. She joined HCB Health from CDM Princeton, where she was Associate Partner, Group Creative Director. Under her leadership, the agency was awarded for its creative excellence by industry associations more than 90 times. Prior to CDM Princeton, she worked at consumer agencies in New York, Denver and Philadelphia helping to build brands such as ESPN and L’Oreal.

Paul Harney has joined Quintiles Commercial North America as Vice President, Business Development. 
 
For more than 18 years, Paul has served the healthcare and life sciences industry with advice, guidance, and business support. He has engaged biopharmaceutical companies in nearly all functional areas including Sales, Marketing, Medical Affairs, Business Development, and Supply Chain.
 
Paul draws on specific expertise in strategy, communications, operations, and analytics at the brand/franchise, division, and corporate levels to identify opportunities to increase value. His extensive experience with retail and institutional products covering several therapy areas such as diabetes, respiratory, anti-infectives, urology, vaccines, and dermatology allows him to quickly leverage best practices and initiatives that enhance go-to-market strategies.

Kristy Junio oversees all aspects of Oracle Marketing Cloud’s global go-to-market strategies focused on the healthcare and life sciences industries. She serves as the subject matter expert in these market segments and supports sales efforts in interacting with customers, analysts, and other industry leaders. Kristy has more than 20 years of experience in advertising and marketing. Before joining Oracle, she spent 13 years in leadership roles with notable healthcare delivery and health insurance companies.

William King is the founder and Executive Chairman of Zephyr Health; the Insights-­as-­a-­Service leader harnessing the power of global health data to address critical business and patient needs. He is passionate about creating innovative solutions to advance efficiency, strategy and tactical problem solving for Life Sciences companies.
Under his leadership, Zephyr Health has grown to serve leading pharmaceutical, biotech, medical device and diagnostic companies globally. Zephyr has also received numerous industry accolades, including being named one of Gartner’s “Cool Vendors in Life Science,” PM360’s “Most Innovative Start-­ups in 2015,” and Insights Success’ “20 Most Valuable Enterprise Big Data Companies.”
At multinational Johnson & Johnson, William held a range of global leadership positions in sales, marketing, training and strategy. He was also a member of the International Development Program for global leadership and people development.
William has participated in some of the industry’s most prestigious conferences including Big Data in BioMedicine, BIO International Convention and Digital Healthcare Innovation Summit. He speaks regularly on:
• What you Need to Know About Creating a Big Data Strategy
• Unfashionably Late to the Big Data Party: How Biopharma Can Catch Up
• The Big Data Prescription for Pharma Marketing
William holds a Bachelor of Science in Business Administration from the University of Denver and serves on the American Heart Association Research Roundtable Executive Board. He currently resides in the Bay Area with his wife and two children.

Mark has spent the last 15 years helping sales leaders shorten the sales cycle and distribute their best ideas faster.  He has also been instrumental in coaching and leading sales teams to deliver a consistent message in the marketplace by integrating iPad technology into their sales processes. He has worked as a presentation coach with a wide range of financial service companies by delivering innovative, practice development and business-building strategies. 

As Nick leads and directs the agency team for a client’s brand assignment, he draws upon his extensive pharmaceutical promotional experience to gather insights, determine a brands optimal selling proposition and formulate strategies to ensure success.  His passion for science and communications is evident in all of his actions.     
Nick has more than 15 years of experience in the rheumatology, metabolic syndrome, neurology, nephrology oncology and pulmonology categories in addition to extensive experience with rare diseases/orphan drugs and biologics.

Will brings more than 15 years of experience in biopharmaceutical commercialization, including significant depth in oncology launch strategy, life-cycle management, pricing, and market access strategy

Recent examples of Will’s work include:

• Biosimilar defense strategy: Developed pricing, contracting, distribution, and value-added service program to minimize impact on multi-billion dollar immunology franchise
• Led product launch strategy and planning for multi-billion dollar opportunity in Hepatitis C; developed sales, marketing, and managed care marketing plans; built detailed long range forecasts based on TPP and developing market dynamics; developed pricing strategy and managed care engagement plan; identified opportunities for “game-changing” innovation with respect to value-based contracting options
• Led development of best-in-class provider and patient support program as cornerstone of novel go-to-market commercial model; determined optimal mix of support services, outcomes reporting tools, and digital platforms as mechanism by which to assure disproportionate share of new patient starts in competitive launch markets
• Developed go-to-market strategy and launch plans for multi-indication oncology product; determined core messaging across central marketing functions based on significant primary and secondary market research analysis

Prior to joining Strategy&, Will has worked in consulting at Deloitte, Oliver Wyman, and, most recently, at Campbell Alliance.  Will worked at Amgen in sales, marketing, life cycle management and licensing/M&A before his consulting career.

HCB Health welcomes Ari Wexler, SVP, Managing Director, to head our NJ/Northeast division.  Ari brings 17+ years of Healthcare marketing & Multichannel experience helping clients and internal commercial marketing departments think more strategically and innovatively within the proverbial pharma “box”.  For the past 4 years, he architected complex, integrated DTC & HCP CRM and MCM strategies for large scale and mid-size pharmaceutical clients, including several brand launches.  Before that, he spent 5 years working for Allergan (formerly Forest Labs) as Director, Multichannel Marketing helping evolve the digital marketing COE into a multifaceted, highly leveraged arm of the organization.  During his tenure, Ari helped Forest move from a “digital production” business to a “multichannel activation” business.  His commitment for triangulating the perfect intersect between great content, creative, and measurable outcomes through the “right channel” enabled brand teams to fund non-traditional marketing strategies while delivering a proven ROI story.  Ari has deep therapeutic category experience in CNS, GI, RA, & Pediatrics.  He believes you can never stop learning, the bar can never be set too high for doing great work, and always be prepared for change.
Ari resides in Scotch Plains, NJ, with his wife Dara and two amazing yet rambunctious 3 year old twins, Jake and Aiden.  In his “spare” time, he can be seen at the local golf course or at the gym.  Ari attended The University of Pittsburgh and holds 2 certifications in digital marketing & marketing analytics.

Within EY’s Commercial Analytics Life Sciences practice and a solution leader of EY’s CASE® (Commercial Analytics Suite).  Dan brings over 10 years of experience in the Life Sciences industry across the commercial value chain, working with clients to optimize performance within the sales, marketing, and market access domains. Dan’s main area of focus is on leveraging advanced and predictive analytics to identify actionable business insights that help clients improve ROI and gain a competitive edge within the industry. Whether it be establishing an innovative product launch strategy via multi-channel execution or optimizing field pull-through tactics to maximize market access profitability, Dan and his team focus on the analytics informing these efforts that are critical to supporting the strategic direction of EY’s clients. Prior to joining EY, Dan worked within the industry for Eli Lilly & Co. as a key account manager, sales operations manager, and sales force effectiveness manager.

Has more than 12 years of experience as a management consultant. He is an expert in commercial strategy, commercial excellence, digital and multichannel, business insights and analytics. He has served and serves Life Sciences companies around the world. He is a senior manager at EY where he is responsible for supporting Life Sciences companies defining and executing their commercial strategy and for developing EY commercial excellence thought leadership. Prior in his career, Alessandro was at McKinsey & Company in both Europe and the US. Alessandro holds a Master of Science in Mechanical Engineering from Politecnico di Torino (Italy), and an MBA from Columbia Business School.

Matt Smith is a senior manager in the Advisory Services practice of EY. Matt has over 16 years of consulting and industry experience, focused on addressing strategic, customer and marketing issues with a particular focus on Life Sciences and Healthcare. He has specific capabilities in strategy development and business model transformation that align the needs of patients, payers, providers and pharmaceutical companies as a result of healthcare reform and the emergence of new digital technologies. Prior to joining EY, Matt held strategy and business analytics positions within Allergan (formerly Actavis), and also spent 10+ years with PA Consulting’s Life Sciences and Healthcare practice. Matt holds a BSc. Management from London School of Economics and a postgraduate diploma in Marketing from CIM.